These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18842532)

  • 1. Symptom management in hepatocellular carcinoma.
    Sun VC; Sarna L
    Clin J Oncol Nurs; 2008 Oct; 12(5):759-66. PubMed ID: 18842532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospice palliative care for patients with hepatocellular carcinoma in Taiwan.
    Lin MH; Wu PY; Tsai ST; Lin CL; Chen TW; Hwang SJ
    Palliat Med; 2004 Mar; 18(2):93-9. PubMed ID: 15046405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients who have undergone hepatic artery chemoembolization.
    Cahill BA
    Clin J Oncol Nurs; 2005 Feb; 9(1):69-75. PubMed ID: 15751500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and treatment of hepatocellular carcinoma in Thailand.
    Chonprasertsuk S; Vilaichone RK
    Jpn J Clin Oncol; 2017 Apr; 47(4):294-297. PubMed ID: 28042136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West.
    Lee VHF; Seong J; Yoon SM; Wong TCL; Wang B; Zhang JL; Chiang CL; Ho PPY; Dawson LA
    Clin Oncol (R Coll Radiol); 2019 Aug; 31(8):560-569. PubMed ID: 31279433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
    Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
    Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of hepatocellular carcinoma].
    Pache I; Bize P; Halkic N; Montemurro M; Giostra E; Majno P; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):198-202. PubMed ID: 20214192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
    Kim SR; Kudo M; Hino O; Han KH; Chung YH; Lee HS;
    Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary management of hepatocellular carcinoma: where are we today?
    Marrero JA
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S3-10. PubMed ID: 23457037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound and fine-needle aspiration for the diagnosis of hepatocellular carcinoma.
    Maheshwari A; Kantsevoy S; Jagannath S; Thuluvath PJ
    Clin Liver Dis; 2010 May; 14(2):325-32. PubMed ID: 20682238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.